Pirfenidone Tablets (Pirfisun 200mg Tablets)

200mg Tablets, Stripe

4.5 (154)

347

Pirfenidone (Pirfisun 200mg Tablet) is an antifibrotic medication used to treat idiopathic pulmonary fibrosis (IPF), slowing disease progression and helping preserve lung function. It works by suppressing TGF-β and limiting collagen production, reducing lung scarring. Taken with food (starting at 267mg three times daily, titrated up to 600mg three times daily), common side effects include nausea, diarrhea, fatigue, and increased sun sensitivity. Regular liver function monitoring is required throughout treatment.

Description

Pirfenidone: Medication Overview

Pirfisun 200mg Tablet is an antifibrotic drug prescribed mainly for idiopathic pulmonary fibrosis (IPF) — a progressive condition in which lung tissue becomes increasingly scarred, gradually impairing breathing capacity.

Indication

  • Idiopathic Pulmonary Fibrosis: Used to slow disease progression and help preserve lung function in people diagnosed with IPF.

Dosing Guidelines

  • Starting dose: 267 mg, three times daily (800 mg/day total).
  • Target/maintenance dose: May be titrated up to 600 mg three times daily (1,800 mg/day total), depending on how well the patient tolerates it and how they respond clinically.
  • How to take it: Swallow with food — this helps the body absorb the drug better and reduces stomach-related side effects.

How It Works

Pirfenidone acts by:

  • Suppressing production of transforming growth factor-beta (TGF-β), a molecule central to the fibrotic process.
  • Limiting collagen synthesis and other fibrosis-promoting substances, which helps slow the buildup of scar tissue in the lungs.

Possible Side Effects

  • Frequently reported: Nausea, diarrhea, tiredness, skin rash, reduced appetite.
  • More serious concerns: Elevated liver enzymes, severe dermatologic reactions, and GI bleeding. Periodic liver function testing is advised throughout treatment.

Safety Precautions

  • Liver health: Check liver enzyme levels both before starting therapy and periodically during treatment, particularly for patients with existing liver conditions.
  • Sun sensitivity: The drug can heighten sunburn risk — patients should apply sunscreen and cover exposed skin when outdoors.
  • Pregnancy: Anyone pregnant or planning pregnancy should review the risks and benefits with their doctor.

Who Shouldn’t Take It

  • Anyone with a known hypersensitivity to pirfenidone or any ingredient in the formulation.

Interactions to Watch For

  • Caution is needed with other drugs that impact liver enzyme activity. Patients should disclose all current medications and supplements to their prescriber.

Storage Instructions

  • Keep at room temperature, protected from light and moisture, and stored safely out of children’s reach.

Guidance for Patients

  • Follow the prescribed regimen fully, even after symptoms start improving.
  • Understand the possible side effects and the need for ongoing liver monitoring.
  • Watch for warning signs like jaundice or severe skin reactions, and contact a healthcare provider right away if they occur.

Conclusion

Pirfenidone (available as Pirfisun 200 mg tablets) offers a meaningful treatment option for managing idiopathic pulmonary fibrosis. Careful adherence, routine monitoring, and patient understanding all contribute to better treatment outcomes. Individuals should always consult their healthcare provider for guidance tailored to their specific situation.

Contact Us

Info Table
Strength 200mg
Packaging Size 10 tablets in 1 strip
Brand Pirfisun 200mg tablets
Composition Pirfenidone 200mg
Manufacturer Sunrise farma
Treatment Swelling in the lungs
Prescription/Non prescription Prescription
Form Tablet
Country of Origin Made in India
Vendor Info
Benefits
Reviews

Description

Pirfenidone: Medication Overview

Pirfisun 200mg Tablet is an antifibrotic drug prescribed mainly for idiopathic pulmonary fibrosis (IPF) — a progressive condition in which lung tissue becomes increasingly scarred, gradually impairing breathing capacity.

Indication

  • Idiopathic Pulmonary Fibrosis: Used to slow disease progression and help preserve lung function in people diagnosed with IPF.

Dosing Guidelines

  • Starting dose: 267 mg, three times daily (800 mg/day total).
  • Target/maintenance dose: May be titrated up to 600 mg three times daily (1,800 mg/day total), depending on how well the patient tolerates it and how they respond clinically.
  • How to take it: Swallow with food — this helps the body absorb the drug better and reduces stomach-related side effects.

How It Works

Pirfenidone acts by:

  • Suppressing production of transforming growth factor-beta (TGF-β), a molecule central to the fibrotic process.
  • Limiting collagen synthesis and other fibrosis-promoting substances, which helps slow the buildup of scar tissue in the lungs.

Possible Side Effects

  • Frequently reported: Nausea, diarrhea, tiredness, skin rash, reduced appetite.
  • More serious concerns: Elevated liver enzymes, severe dermatologic reactions, and GI bleeding. Periodic liver function testing is advised throughout treatment.

Safety Precautions

  • Liver health: Check liver enzyme levels both before starting therapy and periodically during treatment, particularly for patients with existing liver conditions.
  • Sun sensitivity: The drug can heighten sunburn risk — patients should apply sunscreen and cover exposed skin when outdoors.
  • Pregnancy: Anyone pregnant or planning pregnancy should review the risks and benefits with their doctor.

Who Shouldn’t Take It

  • Anyone with a known hypersensitivity to pirfenidone or any ingredient in the formulation.

Interactions to Watch For

  • Caution is needed with other drugs that impact liver enzyme activity. Patients should disclose all current medications and supplements to their prescriber.

Storage Instructions

  • Keep at room temperature, protected from light and moisture, and stored safely out of children’s reach.

Guidance for Patients

  • Follow the prescribed regimen fully, even after symptoms start improving.
  • Understand the possible side effects and the need for ongoing liver monitoring.
  • Watch for warning signs like jaundice or severe skin reactions, and contact a healthcare provider right away if they occur.

Conclusion

Pirfenidone (available as Pirfisun 200 mg tablets) offers a meaningful treatment option for managing idiopathic pulmonary fibrosis. Careful adherence, routine monitoring, and patient understanding all contribute to better treatment outcomes. Individuals should always consult their healthcare provider for guidance tailored to their specific situation.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Pirfenidone Tablets (Pirfisun 200mg Tablets)”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Pirfisun 200mg Tablet used for?
Pirfisun 200mg Tablet contains Pirfenidone, an antifibrotic medication used to treat idiopathic pulmonary fibrosis, a progressive condition where lung tissue scars over time, gradually reducing breathing capacity.
It works by suppressing transforming growth factor-beta (TGF-β), a molecule central to fibrosis, and limiting collagen production, which helps slow the buildup of scar tissue in the lungs.
It’s typically started at 267mg three times daily and gradually increased to 600mg three times daily as tolerated, always taken with food to improve absorption and reduce stomach upset.
Pirfenidone can elevate liver enzymes, so doctors check liver function before starting treatment and periodically afterward, especially in patients with existing liver conditions, to catch problems early.
Yes, it can heighten sunburn risk, so patients are advised to apply sunscreen and cover exposed skin when outdoors, since photosensitivity is a recognized side effect of pirfenidone.
Pirfisun 200mg Tablet contains Pirfenidone 200mg per tablet, manufactured by Sunrise Pharma, supplied as 10 tablets per strip, and classified as a prescription-only antifibrotic medication.

Related products